# Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract Cancers

> **NCT01926236** · PHASE3 · COMPLETED · sponsor: **The Christie NHS Foundation Trust** · enrollment: 162 (actual)

## Conditions studied

- Biliary Tract Cancer
- Gallbladder Cancer
- Cholangiocarcinoma
- Ampullary Cancer

## Interventions

- **OTHER:** Active Symptom Control
- **DRUG:** L-folinic acid
- **DRUG:** 5 FU
- **DRUG:** Oxaliplatin

## Key facts

- **NCT ID:** NCT01926236
- **Lead sponsor:** The Christie NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2018-01-05
- **Final completion:** 2019-01
- **Target enrollment:** 162 (ACTUAL)
- **Last updated:** 2020-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01926236

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01926236, "Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract Cancers". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01926236. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*